WUXI BIO (02269) has announced a significant share repurchase operation conducted on June 18, 2026.
The company allocated a substantial HK$99.735 million to buy back 3.26 million of its own shares on that date.
In a separate corporate action, the firm also issued 12,000 new shares on June 18, 2026. These shares were issued to fulfill the exercise of options under a pre-IPO share option scheme that was initially adopted on January 5, 2016, and subsequently amended on August 10, 2016.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments